NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Sep 04 2024

· Issued by NATCO Pharma Limited

Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated September 04, 2024, titled "NATCO Pharma (Canada) Inc., Subsidiary Company of NATCO Pharma Limited announces US$ 8 million investment in eGenesis, Inc.".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases